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What can it help with?

What is NaProTechnology?

How does it do this?

v Infertility
v Hormonal
v Menstrual Cramps
Abnormalities
v Premenstrual
v Chronic Discharges
Syndrome (PMS)
v Prevention of Preterm
v Ovarian Cysts
Birth
v Irregular or Abnormal v Tubal Occlusion
Bleeding
v Ectopic Pregnancy
v Polycystic Ovarian
v Endometriosis
Syndrome (PCOS)
v Postpartum
v Repetitive Miscarriage Depression (PPD)

NaProTechnology (NPT) is a medical and surgical approach to fertility
care that works synergistically with a woman’s reproductive system. It
does this by identifying the root of the problem and working to correct
it in conjunction with the natural fertility cycle. NPT uses Fertility
Awareness-Based Methods (FABMs), like the Creighton Model System
(CrMS), to diagnose and treat chronic disorders related to infertility.

NaProTechnology utilizes the CrMS cycle tracking
system, individualized hormone assessment,
ultrasound technology, selective
hysterosalpingography, and diagnostic
laparoscopy for the detection, diagnosis, and
treatment of chronic reproductive conditions.

Holistic Health Impacts
ART
Emotional

Relational

↓ stability in relationships
↑ anxiety
↑ depression
↑ stress
↓ libido

Financial

Moral or ethical
dilemmas

Physical
↑ LBW
↑ multiples
↑ breast cancer
↑ miscarriage
↑ ulcerative colitis

$322/cycle (NPT)
CrMS charting materials

Financial

Physical
↓ preterm birth
↓ multiples
↓ LBW
↓ congenital defects

$10,500-$12,500/cycle (IVF)
Oral contraceptives

Relational

Emotional

S. P. I. C. E.

↑ stability in relationships
↓ stress
↑ marital satisfaction

NPT
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Maternal and Fetal Risks of Fertility Interventions
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Nursing Influence & Opportunities
v Patient Education
v Individualized Care
v Engagement in
Nursing Research

v Professional
Development
v CrMS Training
v Advanced Practice
Consultation

v
v
v
v
v
v

Natural Conception
23% high order multiples
7.9% preterm birth
4.9% low birth weight
0.4% monozygosity
0.02% congenital malformation
1.26% maternal morbidity

Assisted Reproductive Technology
v 32% high order multiples
v 9.7% preterm birth
v 6.8% low birth weight
v 1.3% monozygosity
v 0.15% congenital malformation
v 2.73% maternal morbidity

Figure 3: Kawwass, J.F. & Badell, M.L. (2018). Maternal and fetal risk associated with assisted reproductive technology. Obstetrics & Gynecology, 132(3), 763-772. doi: 10.1097/AOG.0000000000002786

Figure 4: Hilgers, T. (2019). Fertility care and naprotechnology: a contemporary approach to women’s health care. Saint Paul VI Institute, 83.

NaProTracking
Figure 4 displays four abnormal menstrual cycles
charted using the Creighton (CrMS) method, or
“NaProTracking”, for women’s health.
v Cycle 1: a limited mucus cycle is seen by few
white and green baby stickers, which often
indicates infertility or miscarriage.
v Cycle 2: a short post-Peak phase is noted,
meaning that there is an inadequate luteal
phase. This is seen in repetitive miscarriage
and is identified by an insufficient number of
solid green stickers at the end of the cycle.
v Cycle 3: premenstrual spotting is recorded as
three or more days of light (L), very light (VL),
or brown (B) bleeding prior to menstruation.
These are seen by red stickers at the end of the
cycle and indicate low progesterone.
v Cycle 4: abnormal bleeding is observed as an
unusually long menstrual phase, followed by
spotting and no cervical mucus build-up. This
is represented by randomized red, solid green,
and white/green baby stickers and is indicative
of a variety of gynecological health problems.

